|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gupta S, Kong W, Peng Y, Miao Q and
Mackillop WJ: Temporal trends in the incidence and survival of
cancers of the upper aerodigestive tract in Ontario and the United
States. Int J Cancer. 125:2159–2165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bergfeld SA and DeClerck YA: Bone
marrow-derived mesenchymal stem cells and the tumor
microenvironment. Cancer Metastasis Rev. 29:249–261. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schmitz S and Machiels JP: Targeting the
tumor environment in squamous cell carcinoma of the head and neck.
Curr Treat Options Oncol. 17:372016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ausoni S, Boscolo-Rizzo P, Singh B, Da
Mosto MC, Spinato G, Tirelli G, Spinato R and Azzarello G:
Targeting cellular and molecular drivers of head and neck squamous
cell carcinoma: Current options and emerging perspectives. Cancer
Metastasis Rev. 35:413–426. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Friedman MS, Long MW and Hankenson KD:
Osteogenic differentiation of human mesenchymal stem cells is
regulated by bone morphogenetic protein-6. J Cell Biochem.
98:538–554. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Short B, Brouard N, Occhiodoro-Scott T,
Ramakrishnan A and Simmons PJ: Mesenchymal stem cells. Arch Med
Res. 34:565–571. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Freitag J, Bates D, Wickham J, Shah K,
Huguenin L, Tenen A, Paterson K and Boyd R: Adipose-derived
mesenchymal stem cell therapy in the treatment of knee
osteoarthritis: A randomized controlled trial. Regen Med.
14:213–230. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Baron R and Rawadi G: Targeting the
Wnt/beta-catenin pathway to regulate bone formation in the adult
skeleton. Endocrinology. 148:2635–2643. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tencerova M, Rendina-Ruedy E, Neess D,
Faergeman N, Figeac F, Ali D, Danielsen M, Haakonsson A, Rosen CJ
and Kassem M: Metabolic programming determines the
lineage-differentiation fate of murine bone marrow stromal
progenitor cells. Bone Res. 7:352019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Corre J, Mahtouk K, Attal M, Gadelorge M,
Huynh A, Fleury-Cappellesso S, Danho C, Laharrague P, Klein B, Rème
T and Bourin P: Bone marrow mesenchymal stem cells are abnormal in
multiple myeloma. Leukemia. 21:1079–1088. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fairfield H, Costa S, Falank C, Farrell M,
Murphy CS, D'Amico A, Driscoll H and Reagan MR: Multiple myeloma
cells alter adipogenesis, increase senescence-related and
inflammatory gene transcript expression, and alter metabolism in
preadipocytes. Front Oncol. 10:5846832020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Battula VL, Le PM, Sun JC, Nguyen K, Yuan
B, Zhou X, Sonnylal S, McQueen T, Ruvolo V, Michel KA, et al:
AML-induced osteogenic differentiation in mesenchymal stromal cells
supports leukemia growth. JCI Insight. 2:e900362017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Martinaud C, Desterke C, Konopacki J,
Pieri L, Torossian F, Golub R, Schmutz S, Anginot A, Guerton B,
Rochet N, et al: Osteogenic potential of mesenchymal stromal cells
contributes to primary myelofibrosis. Cancer Res. 75:4753–4765.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zenner HP, Lehner W and Herrmann IF:
Establishment of carcinoma cell lines from larynx and submandibular
gland. Arch Otorhinolaryngol. 225:269–277. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gioanni J, Fischel JL, Lambert JC, Demard
F, Mazeau C, Zanghellini E, Ettore F, Formento P, Chauvel P and
Lalanne CM: Two new human tumor cell lines derived from squamous
cell carcinomas of the tongue: Establishment, characterization and
response to cytotoxic treatment. Eur J Cancer Clin Oncol.
24:1445–1455. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh
K, Bae YC and Jung JS: Characterization and expression analysis of
mesenchymal stem cells from human bone marrow and adipose tissue.
Cell Physiol Biochem. 14:311–324. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Scherzed A, Hackenberg S, Froelich K,
Kessler M, Koehler C, Hagen R, Radeloff A, Friehs G and Kleinsasser
N: BMSC enhance the survival of paclitaxel treated squamous cell
carcinoma cells in vitro. Cancer Biol Ther. 11:349–357. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Horwitz EM, Le Blanc K, Dominici M,
Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS and
Keating A; International Society for Cellular Therapy, :
Clarification of the nomenclature for MSC: The international
society for cellular therapy position statement. Cytotherapy.
7:393–295. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop D and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The international society for cellular
therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Poggi A and Giuliani M: Mesenchymal
stromal cells can regulate the immune response in the tumor
microenvironment. Vaccines (Basel). 4:412016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Scherzad A, Taeger J, Gehrke TE, Hagen R,
Kleinsasser N and Hackenberg S: Mesenchymal stem cells: Cancer
promoting effects or tumor suppression-A current overview.
Laryngorhinootologie. 97:678–687. 2018.PubMed/NCBI
|
|
25
|
Xia X, Chen W, Ma T, Xu G, Liu H, Liang C,
Bai X, Zhang Y, He Y and Liang T: Mesenchymal stem cells
administered after liver transplantation prevent acute
graft-versus-host disease in rats. Liver Transpl. 18:696–706. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Prockop DJ, Gregory CA and Spees JL: One
strategy for cell and gene therapy: Harnessing the power of adult
stem cells to repair tissues. Proc Natl Acad Sci USA. 100 (Suppl
1):S11917–S11923. 2003. View Article : Google Scholar
|
|
27
|
Cuiffo BG and Karnoub AE: Mesenchymal stem
cells in tumor development: Emerging roles and concepts. Cell Adh
Migr. 6:220–230. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Q, Chai S, Wang W, Wan C, Zhang F,
Li Y and Wang F: Macrophages activate mesenchymal stem cells to
acquire cancer-associated fibroblast-like features resulting in
gastric epithelial cell lesions and malignant transformation in
vitro. Oncol Lett. 17:747–756. 2019.PubMed/NCBI
|
|
29
|
Spaeth EL, Dembinski JL, Sasser AK, Watson
K, Klopp A, Hall B, Andreeff M and Marini F: Mesenchymal stem cell
transition to tumor-associated fibroblasts contributes to
fibrovascular network expansion and tumor progression. PLoS One.
4:e49922009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mishra PJ, Mishra PJ, Humeniuk R, Medina
DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW and Banerjee D:
Carcinoma-associated fibroblast-like differentiation of human
mesenchymal stem cells. Cancer Res. 68:4331–4339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Z, Liu C, Xie Z, Song P, Zhao RC, Guo
L, Liu Z and Wu Y: Epigenetic dysregulation in mesenchymal stem
cell aging and spontaneous differentiation. PLoS One. 6:e205262011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tu B, Peng ZX, Fan QM, Du L, Yan W and
Tang TT: Osteosarcoma cells promote the production of pro-tumor
cytokines in mesenchymal stem cells by inhibiting their osteogenic
differentiation through the TGF-β/Smad2/3 pathway. Exp Cell Res.
320:164–173. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Paino F, La Noce M, Di Nucci D, Nicoletti
GF, Salzillo R, De Rosa A, Ferraro GA, Papaccio G, Desiderio V and
Tirino V: Human adipose stem cell differentiation is highly
affected by cancer cells both in vitro and in vivo: Implication for
autologous fat grafting. Cell Death Dis. 8:e25682017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wolfson B, Eades G and Zhou Q: Adipocyte
activation of cancer stem cell signaling in breast cancer. World J
Biol Chem. 6:39–47. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Banerjee K and Resat H: Constitutive
activation of STAT3 in breast cancer cells: A review. Int J Cancer.
138:2570–2578. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Heinrich PC, Behrmann I, Haan S, Hermanns
HM, Muller-Newen G and Schaper F: Principles of interleukin
(IL)-6-type cytokine signalling and its regulation. Biochem J.
374:1–20. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Galic S, Oakhill JS and Steinberg GR:
Adipose tissue as an endocrine organ. Mol Cell Endocrinol.
316:129–139. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pacini S: Deterministic and stochastic
approaches in the clinical application of mesenchymal stromal cells
(MSCs). Front Cell Dev Biol. 2:502014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pevsner-Fischer M, Levin S and Zipori D:
The origins of mesenchymal stromal cell heterogeneity. Stem Cell
Rev. 7:560–568. 2011. View Article : Google Scholar : PubMed/NCBI
|
